Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well at least you won't be on when this boat sinks.
If if there were evidence of 3 dogs in each 10 dog study (in which there are 3 and 1 respectively) those studies would still be considered a joke. Wait they are. I went to read the original pr for the first study but could not find it bc it is so dated.
I think it just confirmed its formation.
Did you ask for another fluff pr before close?
There are no pr's that reflect your claims on the number of dogs in the second study or a feline study. Even if they're were I would prefer them to finish at least one project before they start a third.
Thats not what I said. Don't let your emotions influence your trading.
Sho nuff. Go chart analysis!
Thats why I think it stinks of P&D. The FDA news is a distraction. Like I said, it trumps the biopsy news now. Even if the biopsy news is good nothing major can happen here until approval news which is AT LEAST 6 months away.
They are influences by pr's when pr's are released and then they drop like stones when the fluff comes to the top and the chart patterns continue (I know, run on sentence). However, I am not telling you anything you don't already know.
At this point I am only gonna play the chart. When the indicators head up and the momentum is there I will consider it. I don't "buy the dip" and go for the MM manipulation stuff. Been burned there before. If biopsy news is solid I may jump in for a short ride then wait until the run-up to FDA approval. I honestly see this headed for lower resistance levels.
I know there are people who think I am lying but charts show patterns that will emerge and it takes a few trading sessions to happen. If you look at my posts versus this who say this is going to a buck, who has been more accurate?
I have been calling the chart formation and doubting the pr's true. I was emailing the co to do more dd, especially after the second pr reporting the same results. At first I was all in and then sold. Keep in mind the chart is doing what I said it would. Unless there are more pr's it goes down.
I wrote them on 1/23 regarding legal issues and last fri regarding the using photos as study results. Have heard nothing back.
I write all companies that I buy into and when they don't write back it generally does not bode well for the future.
You have insider information and are reporting here that you have information about the 1 and 3 dog studies? Please share more.
Anything regarding the feline study is still speculation.
I respectfully disagree. Not with a red, flat, and red close the last three sessions.
Happy to explain how I see it. The head and shoulders is often less dramatic in shape in penny plays bc they tend to rise and fall o news so quickly. I have circled all three parts. Todays close however was a bit less red then I expected. Though todays news was good overall I see the pps declining from here because whether the biopsy results are good or bad, the FDA decision is the next big news, imo. Happy to talk charts with other chartists. Good luck!
I respect your posts when they are honest. You said that both studies had 3 dogs and there is a feline study when in fact it is not true.
No kidding especially bc they mentioned they could sell it in states where pot is legal in a pr headline regarding the FDA. What a joke.
This chart sure isn't. Down 4% on news.
They trumped biopsy results with todays news. Biopsy results now, even if positive, cannot speed up the FDA fast track.
I think we should stick to published facts.
This will sell off until there is FDA news in 6 months or t least it will be a choppy decline. Careful it under REVIEW has not been approved.
"Erivedge, reviewed under the agency’s priority review program, is the first FDA-approved drug for metastatic basal cell carcinoma. Erivedge was reviewed under the FDA’s priority review program that provides for an expedited six-month review of drugs that may offer major advances in treatment. The drug is being approved ahead of the March 8, 2012 prescription user fee goal date."
LOL, yes they do. But here I would argue that three pr's that essentially reported the same findings was not able to capture the audience. My post may be redundant but they are honest and based on technicals. I will post another daily chart to keep people abreast of where this is going. Sell signals for three days in a row. I called this last week
Head and shoulders pattern technically formed. If this closes at the current -8% or greater a much greater sell off commences. I have been calling this straight through all the fluff prs's because technical indicators have been trending down since late last week.
.
http://www.investopedia.com/terms/h/head-shoulders.asp#axzz1l9HOHlTl
There is no safety net above .033 with .043 broken. It may hang in at .030 range for a day bu wll quickly hit the 0.024 support. No buy signal here.
1st study: 3/10 dogs; 2nd study 1/10 is what I still READ in pr's. No news about a feline study that I READ. Your sources say otherwise? Where are you HEARING that? Please share!
If they don't give some real news soon the chart indicates it will drop like a stone. Wound tight. Good luck
As far as the dog studies go maybe they should have waited until they had 10 dogs bc 3 dog studies are a joke.
And the feline study?
Hopefully they will wait until they have ten cats before they pr that study if there is even being considered.
I'll sticky the link to the cat study for you.
Any progress on either of the ten dog studies?
Would have gone to $15? That possibility came and went. Investors lost confidence here. Koos has shown no follow through. Hypothesis about nss is purely speculation.
O this is tenuous. Market indecisive still. Who will win?
I gather you know exactly where it happened and when. Same cast of characters, maybe different aliases on two chat sites. There are few folks on IHUB who are very influential and I am sure with your excellent understanding of the market and research skills it has not eluded you. ENTB is down 98% since Feb of 2011.
You do bring interesting theories to the board.
Good luck
You need to familiarize yourself with how companies get FDA approval for drugs. Do your DD!
Unfortunately without substantive news that move will be south.
Without conducting a scientific study there is no proof. Pictures are interesting but clinical trials would be required.
I understand that but this is not a smoke shop product. If it were being taken seriously it would not be down 2%. I think I am going to back to charts bc this chart is heading right where I said it was. Slowly but surely.
Yes, and the Feds have no plan the stop prosecuting thus ignoring state decriminalization. This product does not use Marinol which is synthetic nor Sativex. With a screwed up FDA and criminal law in the way. It will be a bumpy ride.
Product info:
http://www.cannabisscience.com/products.html
So, very unlikely.
ENTB was a great P&D. Go back to view posts on this board about one year ago to verify.